Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 72Recruiting 38Unknown 34Terminated 24Active not recruiting 9Not yet recruiting 6Withdrawn 5Suspended 3Enrolling by invitation 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Meningioma 1

Interventions

Specimen Handling 31Magnetic Resonance Spectroscopy 19Biopsy 16Cyclophosphamide 15Nivolumab 10Paclitaxel 9Vincristine 8Cisplatin 8venetoclax 7Prednisone 7Gemcitabine 7Doxorubicin 7Bevacizumab 7Azacitidine 7pembrolizumab 6Radiotherapy 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Surgical Procedures, Operative 5Rituximab 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Injections 5Everolimus 5Capecitabine 5fludarabine phosphate 4Taxes 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Suspended × Magnetic Resonance Imaging × Clear all
NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Thomas Jefferson University

Phase 1 Suspended
24 enrolled
CNS

Meningioma

NCT03500081 2026-01-12

Solid Tumor Imaging MR-Linac (STIM Study)

Medical College of Wisconsin

Suspended
295 enrolled
Tumor-Agnostic

Neoplasms

NCT06185478 2023-12-29

Prostate Diffusion Imaging With Distortion Correction

Norfolk and Norwich University Hospitals NHS Foundation Trust

Phase NA Suspended
70 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡